Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
When COVID-19 patients head home, the challenges continue | New data on empagliflozin | PCI & subclinical hypothyroidism
Tuesday, January 19, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

When hospitalized COVID-19 patients head home, the cardiovascular challenges continue

The research included data from more than 47,000 hospitalized COVID-19 patients. 

READ MORE >
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID
Share on Twitter Share on Facebook Share on Linkedin

When hospitalized COVID-19 patients head home, the cardiovascular challenges continue

Share on Twitter Share on Facebook Share on Linkedin
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID
The research included data from more than 47,000 hospitalized COVID-19 patients. 
READ MORE >

Empagliflozin provides additional benefits to patients with type 2 diabetes and CAD

The authors found a link between six months of empagliflozin and a reduction in extracellular volume, sharing their findings in JACC: Cardiovascular Imaging.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Empagliflozin provides additional benefits to patients with type 2 diabetes and CAD

Share on Twitter Share on Facebook Share on Linkedin
The authors found a link between six months of empagliflozin and a reduction in extracellular volume, sharing their findings in JACC: Cardiovascular Imaging.
READ MORE >

Why STEMI patients undergoing PCI should be tested for subclinical hypothyroidism

For patients undergoing PCI, subclinical hypothyroidism was associated with higher short-term and long-term mortality.

READ MORE >
family visits with doctor
Share on Twitter Share on Facebook Share on Linkedin

Why STEMI patients undergoing PCI should be tested for subclinical hypothyroidism

Share on Twitter Share on Facebook Share on Linkedin
family visits with doctor
For patients undergoing PCI, subclinical hypothyroidism was associated with higher short-term and long-term mortality.
READ MORE >

Featured Articles

How to predict heart failure among patients with diabetes, prediabetes

Researchers were able to predict, with considerable accuracy, each patient's 5- and 10-year risk of heart failure. 

READ MORE >
diabetes
Share on Twitter Share on Facebook Share on Linkedin

How to predict heart failure among patients with diabetes, prediabetes

Share on Twitter Share on Facebook Share on Linkedin
diabetes
Researchers were able to predict, with considerable accuracy, each patient's 5- and 10-year risk of heart failure. 
READ MORE >

American Heart Association on the COVID-19 vaccine: ‘We urge everyone to get vaccinated’

“Some people have expressed concerns about taking the vaccine,” the AHA wrote. “However, after review by science and medical experts, the association is confident the benefits of vaccination far exceed the very small, rare risks."

READ MORE >
Vaccination
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association on the COVID-19 vaccine: ‘We urge everyone to get vaccinated’

Share on Twitter Share on Facebook Share on Linkedin
Vaccination
“Some people have expressed concerns about taking the vaccine,” the AHA wrote. “However, after review by science and medical experts, the association is confident the benefits of vaccination far exceed the very small, rare risks."
READ MORE >

Beta-blockers make little difference for heart attack patients without heart failure or LVSD

The researchers, sharing their work in the American Journal of Cardiology, suggested multiple reasons why this may be the case. 

READ MORE >
The American College of Cardiology (ACC) has published a new guidance document focused on the treatment of patients who present with atherosclerotic cardiovascular disease (ASCVD) and other chronic conditions sch as hypertension, diabetes and atrial fibrillation (AFib).
Share on Twitter Share on Facebook Share on Linkedin

Beta-blockers make little difference for heart attack patients without heart failure or LVSD

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology (ACC) has published a new guidance document focused on the treatment of patients who present with atherosclerotic cardiovascular disease (ASCVD) and other chronic conditions sch as hypertension, diabetes and atrial fibrillation (AFib).
The researchers, sharing their work in the American Journal of Cardiology, suggested multiple reasons why this may be the case. 
READ MORE >

Health system boosts cardiac rehab rates, improves patient care, with new referral process

Straightforward, easy-to-replicate changes helped transform a hospital's CR referral rates. 

READ MORE >
cardiac rehab
Share on Twitter Share on Facebook Share on Linkedin

Health system boosts cardiac rehab rates, improves patient care, with new referral process

Share on Twitter Share on Facebook Share on Linkedin
cardiac rehab
Straightforward, easy-to-replicate changes helped transform a hospital's CR referral rates. 
READ MORE >

From the Magazine

Succession Planning: Prepare Your Practice to Survive the Retirement Tsunami

Succession planning is about a practice’s top job, but it’s not *only* about the top job.

READ MORE >
succession_planning.png
Share on Twitter Share on Facebook Share on Linkedin

Succession Planning: Prepare Your Practice to Survive the Retirement Tsunami

Share on Twitter Share on Facebook Share on Linkedin
succession_planning.png
Succession planning is about a practice’s top job, but it’s not *only* about the top job.
READ MORE >

In Other News

Radiology provider Envision suspending contributions to lawmakers who opposed election certification

CEO Jim Rechtin said the pause will last through 2021, emphasizing that the physician firm’s political activities must reflect “our values as a national medical group."

READ MORE >
jim_retchin_envision_president_ceo.jpg
Share on Twitter Share on Facebook Share on Linkedin

Radiology provider Envision suspending contributions to lawmakers who opposed election certification

Share on Twitter Share on Facebook Share on Linkedin
jim_retchin_envision_president_ceo.jpg
CEO Jim Rechtin said the pause will last through 2021, emphasizing that the physician firm’s political activities must reflect “our values as a national medical group."
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme